Actinogen Medical Limited

ASX:ACW Voorraadrapport

Marktkapitalisatie: AU$73.6m

Actinogen Medical Toekomstige groei

Future criteriumcontroles 2/6

Actinogen Medical's earnings are forecast to decline at 22.1% per annum while its annual revenue is expected to grow at 20% per year. EPS is expected to decline by 0.01% per annum.

Belangrijke informatie

-22.1%

Groei van de winst

-0.009%

Groei van de winst per aandeel

Biotechs winstgroei15.2%
Inkomstengroei20.0%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerkt31 Oct 2024

Recente toekomstige groei-updates

Recent updates

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Apr 30
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Nov 16
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

Aug 02
Is Actinogen Medical (ASX:ACW) In A Good Position To Invest In Growth?

We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

Apr 12
We Think Actinogen Medical (ASX:ACW) Can Afford To Drive Business Growth

We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Nov 28
We're Hopeful That Actinogen Medical (ASX:ACW) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Aug 09
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

Apr 07
Here's Why We're Not Too Worried About Actinogen Medical's (ASX:ACW) Cash Burn Situation

We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Oct 24
We're Not Worried About Actinogen Medical's (ASX:ACW) Cash Burn

Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

Jul 11
Actinogen Medical (ASX:ACW) Is In A Strong Position To Grow Its Business

We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

Mar 27
We're Interested To See How Actinogen Medical (ASX:ACW) Uses Its Cash Hoard To Grow

How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Jan 07
How Does Actinogen Medical's (ASX:ACW) CEO Pay Compare With Company Performance?

Winst- en omzetgroeiprognoses

ASX:ACW - Toekomstschattingen van analisten en financiële gegevens uit het verleden (AUD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
6/30/202614-20-13N/A1
6/30/20257-12-9N/A1
6/30/202410-13-17-17N/A
3/31/20247-14-15-15N/A
12/31/20235-15-13-13N/A
9/30/20235-13-11-11N/A
6/30/20235-11-9-9N/A
3/31/20235-11-9-9N/A
12/31/20225-11-9-9N/A
9/30/20224-10-9-9N/A
6/30/20224-9-10-10N/A
3/31/20223-8-8-8N/A
12/31/20212-7-6-6N/A
9/30/20212-6-4-4N/A
6/30/20212-4-2-2N/A
3/31/20212-4-2-2N/A
12/31/20203-4-2-2N/A
9/30/20203-4-3-3N/A
6/30/20204-5-3-3N/A
3/31/20205-6-5-5N/A
12/31/20196-7-7-7N/A
9/30/20195-8-9-9N/A
6/30/20195-10-10-10N/A
3/31/20194-10-10-10N/A
12/31/20183-10-9-9N/A
9/30/20183-8-8-8N/A
6/30/20183-6-8-8N/A
3/31/20182-6N/A-6N/A
12/31/20172-5N/A-4N/A
9/30/20171-4N/A-3N/A
6/30/20171-3N/A-1N/A
3/31/20172-4N/A-2N/A
12/31/20163-4N/A-2N/A
9/30/20163-4N/A-4N/A
6/30/20164-4N/A-5N/A
3/31/20163-5N/A-5N/A
12/31/20151-5N/A-5N/A
9/30/20151-5N/A-4N/A
6/30/20150-5N/A-4N/A
3/31/20150-3N/A-2N/A
12/31/20140-2N/A-1N/A
9/30/20140-1N/A-1N/A
6/30/201400N/A0N/A
3/31/201400N/A0N/A
12/31/201300N/A0N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: ACW is forecast to remain unprofitable over the next 3 years.

Winst versus markt: ACW is forecast to remain unprofitable over the next 3 years.

Hoge groeiwinsten: ACW is forecast to remain unprofitable over the next 3 years.

Omzet versus markt: ACW's revenue (20% per year) is forecast to grow faster than the Australian market (5.7% per year).

Hoge groei-inkomsten: ACW's revenue (20% per year) is forecast to grow faster than 20% per year.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if ACW's Return on Equity is forecast to be high in 3 years time


Ontdek groeibedrijven